Zink and Bone Strength

This study has been completed.

Sponsors and Collaborators:	Northern Orthopaedic Division, Denmark CCBR
Information provided by:	Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier:	NCT00317863

Purpose

Zink and bone strength

Condition
Coxarthrosis Fracture of Femoral Neck

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Zink and Bone Strength

Further study details as provided by Northern Orthopaedic Division, Denmark:

Estimated Enrollment:	40
Study Start Date:	January 2004
Study Completion Date:	December 2006

Detailed Description:

blood- and urine samples collected from 20 OA patients and 20 osteoporosis patients who all had a hip-replacement. All patients were evaluated by DEXA-scanning.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Postmenopausal women with osteoarthrosis or femoral neck-fracture i one hip

Exclusion Criteria:

pathology or prosthesis in contralateral hip

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00317863

Locations

Denmark, Northern Jutland
Northern Orthopaedic Division, Klinik Farsoe
Farsoe, Northern Jutland, Denmark

Sponsors and Collaborators

Northern Orthopaedic Division, Denmark

CCBR

Investigators

Principal Investigator:

Janne Ovesen, MD

Northern Orthopaedic Division

More Information

Study ID Numbers:	ON-04-003-JO
Study First Received:	April 23, 2006
Last Updated:	October 26, 2007
ClinicalTrials.gov Identifier:	NCT00317863
Health Authority:	Denmark: The Danish National Committee on Biomedical Research Ethics

Study placed in the following topic categories:

Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis

Fractures, Bone
Rheumatic Diseases
Osteoarthritis, Hip

ClinicalTrials.gov processed this record on January 16, 2009